Catalyst Wire Dossier Catalyst Wire Dossier

Investigational regimen combining FDA-approved HIV drugs

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational regimen combining FDA-approved HIV drugs, covering 2015-04-08 to 2015-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure [Phase 4]

See pricing